Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 875 | $14K |
| Grant or award | 18 | 193,086 | |
| Bona-fide gift | 2 | 1,358,746 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
37 Form 4 filings on record, the earliest from Oct 16, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kenneth Patrick Lorton - Officer | Open-market sale | Common Stock | 925 | $13.73 | $13K | |
| Jenny Herman - Officer | Open-market sale | Common Stock | 752 | $13.79 | $10K | |
| Robert Lorne Abel - Officer | Open-market sale | Common Stock | 1,230 | $13.51 | $17K | |
| Margaret Dugan - Officer | Open-market sale | Common Stock | 1,395 | $21.07 | $29K | |
| Arun Oberoi - Director | Grant or award | Common Stock | 5,997 | $0.00 | - | |
| Arun Oberoi - Director | Grant or award | Stock Option (right to buy) | 9,341 | $0.00 | - | |
| Gary L. Ginsberg - Director | Grant or award | Common Stock | 5,997 | $0.00 | - | |
| Gary L. Ginsberg - Director | Grant or award | Stock Option (right to buy) | 9,341 | $0.00 | - | |
| Margaret Dugan - Officer | Open-market sale | Common Stock | 1,531 | $17.78 | $27K |
This is as far as the anonymous view goes. Create a free account for all 37 SDGR filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Schrodinger, Inc. (SDGR) had 11 insider filings in the last 90 days, with the most recent on 2026-07-17. The full record for SDGR runs to 37 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of SDGR were filed in the last 90 days.
1 insider sale of SDGR was filed in the last 90 days, totaling $14K.
This page tracks SDGR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add SDGR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.